Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

9-cis-Retinyl acetate

EU orphan designation number: EU/3/11/865   
Active ingredient: 9-cis-Retinyl acetate
Indication: Treatment of retinitis pigmentosa
Sponsor: QLT Ophthalmics (UK), Ltd
3 More London Riverside, London SE1 2AQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/05/2011 Orphan designation EMA/OD/162/10 (2011)3491 of 13/05/2011
18/11/2011 Transfer of orphan designation EMA/OD/162/10/T/01 (2011)8535 of 16/11/2011
8/04/2019 Change of name and/or address of sponsor